Privia Health Group Inc (PRVA) Stock Price, Quote & News

Company Profile

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial ince...

Industry: Health Information Services

Sector: Healthcare

Phone: 571 366 8850

Fax: 813 315 6180

Website: www.priviahealth.com

Address:

950 North Glebe Road, Suite 700, Arlington, United States

GoldenTradesCapital Jun. 15 at 4:17 PM

🏥 $PRVA – Healthcare SaaS for Doctors Privia Health delivers software and support services to medical practices. $PRVA is profitable, growing fast, and benefiting from the physician ownership trend.

0 · Reply

Samurai_QQQ Jun. 3 at 9:31 PM

$PRVA Long 200 shares at $22.94. Stop loss at $22.12. Looking for another run and through recent highs at $26.

0 · Reply

JarvisFlow May. 28 at 3:51 PM

JP Morgan has updated their rating for Privia Health Gr ( $PRVA ) to Overweight with a price target of 32.

0 · Reply

macroaxis May. 11 at 1:30 PM

$PRVA - Privia options price warning: put open interest is down to 166.0 https://www.macroaxis.com/stock-options/PRVA/Privia-Health-Group?utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

IN0V8 May. 9 at 3:45 PM

$PRVA Buy Leerink Partners raises target price to $32 from $30 Piper Sandler raises target price to $36 from $35

0 · Reply

Doozio May. 8 at 2:10 PM

$PRVA eps gap n goes INTA 🐒🍌🧠⏰♾️

0 · Reply

JarvisFlow Apr. 28 at 2:51 PM

JMP Securities has adjusted their stance on Privia Health Gr ( $PRVA ), setting the rating to Market Outperform with a target price of 29.

0 · Reply

JarvisFlow Apr. 15 at 12:30 PM

Baird updates rating for Privia Health Gr ( $PRVA ) to Outperform, target set at 24 → 26.

0 · Reply

Winning_calls Apr. 14 at 12:45 PM

$PRVA 👋👋👋

0 · Reply

Winning_calls Apr. 14 at 2:00 AM

$PRVA pick me up @ $24.25

0 · Reply

Privia Health Group, Inc. (PRVA) Q1 2025 Earnings Call Transcript

May 8, 2025, 6:00 AM EDT - 7 weeks ago

Privia Health Reports First Quarter 2025 Financial Results

Mar 4, 2025, 7:03 AM EST - 4 months ago

Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025

CORT GILD TGTX TKO

Feb 27, 2025, 9:36 AM EST - 4 months ago

Privia Health Group, Inc. (PRVA) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 6:00 AM EST - 4 months ago

Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results

Jan 24, 2025, 9:00 AM EST - 5 months ago

Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27

Nov 8, 2024, 3:50 PM EST - 8 months ago

Privia Health Group, Inc. (PRVA) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 6:00 AM EST - 8 months ago

Privia Health Reports Third Quarter 2024 Financial Results

Oct 29, 2024, 5:04 PM EDT - 8 months ago

Privia Health Reports 2023 Performance Results in the Medicare Shared Savings Program

Aug 8, 2024, 12:45 PM EDT - 11 months ago

Privia Health Group, Inc. (PRVA) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 6:00 AM EDT - 11 months ago

Privia Health Reports Second Quarter 2024 Financial Results

May 30, 2024, 9:26 AM EDT - 1 year ago

Privia Health to Participate in the William Blair Growth Stock Conference

May 11, 2024, 10:35 AM EDT - 1 year ago

Privia Health Group, Inc. (PRVA) Q1 2024 Earnings Call Transcript

May 9, 2024, 6:00 AM EDT - 1 year ago

Privia Health Reports First Quarter 2024 Financial Results

Apr 9, 2024, 9:00 AM EDT - 1 year ago

Privia Health to Report First Quarter 2024 Results on Thursday, May 9

Feb 27, 2024, 10:40 AM EST - 1 year ago

Privia Health Group, Inc. (PRVA) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 6:00 AM EST - 1 year ago

Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results

Jan 29, 2024, 8:30 AM EST - 1 year ago

Privia Health Appoints Edward C. Fargis as General Counsel

Jan 23, 2024, 8:30 AM EST - 1 year ago

Privia Health to Report Fourth Quarter and Full-Year 2023 Results on Tuesday, February 27

Dec 14, 2023, 1:24 PM EST - 1 year ago

Best Small-Cap Stocks to Buy for 2024 and Beyond

ARVN ASO BOOT FLYW GH IMVT RCKT

Dec 12, 2023, 9:00 AM EST - 1 year ago

Privia Health to Participate in the J.P. Morgan Healthcare Conference

Nov 7, 2023, 9:00 AM EST - 1 year ago

Calm Waters AI Announces Agreement with Physician-Led Privia Health

Nov 5, 2023, 8:51 AM EST - 1 year ago

Privia Health Group, Inc (PRVA) Q3 2023 Earnings Call Transcript

Nov 3, 2023, 6:30 AM EDT - 1 year ago

Privia Health Reports Third Quarter 2023 Financial Results; Announces New Market Entry in South Carolina

Oct 11, 2023, 8:30 AM EDT - 1 year ago

Privia Health to Report Third Quarter 2023 Results on Friday, November 3

Sep 14, 2023, 9:00 AM EDT - 1 year ago

Navina and Privia Health Join Forces to Empower Physicians with Transformative AI Technology

Sep 6, 2023, 9:00 AM EDT - 1 year ago

Privia Health to Participate in the Morgan Stanley Healthcare Conference

Aug 25, 2023, 8:33 AM EDT - 1 year ago

Privia Health Reports Results in CMS' Medicare Shared Savings Program for the 2022 Performance Year

Aug 16, 2023, 10:55 PM EDT - 2 years ago

Privia Health: Unit Economics Stretching Higher At Qualified Growth Rates (Rating Upgrade)

Aug 6, 2023, 2:05 PM EDT - 2 years ago

Privia Health Group, Inc. (PRVA) Q2 2023 Earnings Call Transcript

Aug 3, 2023, 6:30 AM EDT - 2 years ago

Privia Health Reports Second Quarter 2023 Financial Results

Jul 31, 2023, 9:00 AM EDT - 2 years ago

Privia Health Announces Changes to Board of Directors

Jul 11, 2023, 9:00 AM EDT - 2 years ago

Privia Health to Report Second Quarter 2023 Results on Thursday, August 3

Jul 11, 2023, 7:09 AM EDT - 2 years ago

Velocity and Privia Health Enter Partnership to Embed Clinical Research Into Practice Sites

Jun 29, 2023, 9:00 AM EDT - 2 years ago

Privia Health Announces Expansion of and Changes to Board of Directors

May 31, 2023, 6:35 PM EDT - 2 years ago

Privia Health Group: Platform Contribution And Capitated Book Performed Strongly

May 31, 2023, 9:00 AM EDT - 2 years ago

Privia Health to Participate in Upcoming Investor Conferences

May 6, 2023, 7:10 PM EDT - 2 years ago

Privia Health Group, Inc. (PRVA) Q1 2023 Earnings Call Transcript

May 4, 2023, 9:14 AM EDT - 2 years ago

Privia Health Announces Upsized Pricing of Secondary Offering of $936 Million of Common Stock

May 4, 2023, 8:30 AM EDT - 2 years ago

Privia Health Announces Pricing of Secondary Offering of $689 Million of Common Stock

May 4, 2023, 6:32 AM EDT - 2 years ago

Privia Health Announces Secondary Offering

May 4, 2023, 6:30 AM EDT - 2 years ago

Privia Health Reports First Quarter 2023 Financial Results

Apr 11, 2023, 9:00 AM EDT - 2 years ago

Privia Health to Report First Quarter 2023 Results on Thursday, May 4

Mar 31, 2023, 7:06 AM EDT - 2 years ago

Privia Health Group: Promising Outlook Ahead

Mar 7, 2023, 9:00 AM EST - 2 years ago

Privia Health and OhioHealth Health System Sign Definitive Partnership

Mar 3, 2023, 3:39 PM EST - 2 years ago

Privia Health Group, Inc. (PRVA) Q4 2022 Earnings Call Transcript

Feb 28, 2023, 6:30 AM EST - 2 years ago

Privia Health Reports Fourth Quarter 2022 Financial Results

Feb 17, 2023, 9:00 AM EST - 2 years ago

Privia Health Enters Connecticut with Community Medical Group, a Clinically Integrated Network with approximately 1,100 Providers

Jan 26, 2023, 9:00 AM EST - 2 years ago

Privia Health to Report Fourth Quarter 2022 Results on Tuesday, February 28

Jan 17, 2023, 4:45 PM EST - 2 years ago

Privia Health Launches Two New Accountable Care Organizations

GoldenTradesCapital Jun. 15 at 4:17 PM

0 · Reply

Samurai_QQQ Jun. 3 at 9:31 PM

$PRVA Long 200 shares at $22.94. Stop loss at $22.12. Looking for another run and through recent highs at $26.

0 · Reply

JarvisFlow May. 28 at 3:51 PM

JP Morgan has updated their rating for Privia Health Gr ( $PRVA ) to Overweight with a price target of 32.

0 · Reply

macroaxis May. 11 at 1:30 PM

$PRVA - Privia options price warning: put open interest is down to 166.0 https://www.macroaxis.com/stock-options/PRVA/Privia-Health-Group?utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

IN0V8 May. 9 at 3:45 PM

$PRVA Buy Leerink Partners raises target price to $32 from $30 Piper Sandler raises target price to $36 from $35

0 · Reply

Doozio May. 8 at 2:10 PM

$PRVA eps gap n goes INTA 🐒🍌🧠⏰♾️

0 · Reply

JarvisFlow Apr. 28 at 2:51 PM

JMP Securities has adjusted their stance on Privia Health Gr ( $PRVA ), setting the rating to Market Outperform with a target price of 29.

0 · Reply

JarvisFlow Apr. 15 at 12:30 PM

Baird updates rating for Privia Health Gr ( $PRVA ) to Outperform, target set at 24 → 26.

0 · Reply

Winning_calls Apr. 14 at 12:45 PM

$PRVA 👋👋👋

0 · Reply

Winning_calls Apr. 14 at 2:00 AM

$PRVA pick me up @ $24.25

0 · Reply

Doozio Apr. 13 at 12:01 AM

$PRVA Barclays don’t know 💩!

0 · Reply

Doozio Apr. 12 at 11:57 PM

$PRVA out of 🐑 amania a 🧠 returns.

0 · Reply

Doozio Apr. 12 at 5:36 PM

$PRVA same church different pew. Timing matters n yo IPO’d at the wrong one. Monthly appears ready to Roger as new leadership emerges outta 🐑 amania.

0 · Reply

JarvisFlow Apr. 10 at 3:36 PM

Barclays has adjusted their stance on Privia Health Gr ( $PRVA ), setting the rating to Equal-Weight with a target price of 21 → 23.

0 · Reply

JarvisFlow Apr. 10 at 12:32 PM

Truist Securities has updated their rating for Privia Health Gr ( $PRVA ) to Buy with a price target of 28.

0 · Reply

JarvisFlow Apr. 10 at 10:30 AM

Needham has adjusted their stance on Privia Health Gr ( $PRVA ), setting the rating to Buy with a target price of 30.

0 · Reply

Thestocktraderhubzee Apr. 10 at 10:26 AM

WATCHLIST APR 10 2025 $IDYA Ideaya Biosciences Initiated Phase 1/2 Expansion In The Clinical Trial Evaluating IDE397 In Combination With Gilead's Trodelvy In Methylthioadenosine Phosphorylase-deletion Urothelial Cancer Based On Preliminary Safety And Clinical Efficacy Data $RSLS ReShape Lifesciences shares are trading higher after the company announced a partnership with Motion Informatics to exclusively import and distribute neuromuscular rehabilitation devices in the US. $BWXT BWX Technologies Joint Venture Strategic Storage Partners Awarded Strategic Petroleum Reserve Contract; Estimated Value Of The Contract Is ~$2.6B Over 10 Years $OLN Wells Fargo Maintains Equal-Weight on Olin, Lowers Price Target to $19 $PRVA Privia Health Group Signs Definitive Agreement To Enter Arizona In Partnership With Integrated Medical Services. Group Manages Over 28,000 Attributed Lives

0 · Reply

NVDAMillionaire Mar. 25 at 12:31 AM

$PRVA Privia's healthcare model looks promising. Expanding provider network and value-based care strategy positioning them well. Might add a small position on potential healthcare tech growth. Watching closely for next earnings report and market reaction. insightful article: https://beyondspx.com/article/privia-health-group-inc-nasdaq-prva-building-a-market-leading-primary-care-centric-delivery-network

0 · Reply

JarvisFlow Mar. 21 at 12:30 PM

Needham has updated their rating for Privia Health Gr ( $PRVA ) to Buy with a price target of 30.

0 · Reply

IN0V8 Feb. 28 at 6:59 PM

$PRVA BTIG raises target price to $35 from $30 TD Cowen raises target price to $30 from $26 Truist Securities raises target price to $30 from $27 UBS raises target price to $31 from $27

1 · Reply

JarvisFlow Feb. 28 at 4:02 PM

Citizens Capital Markets has updated their rating for Privia Health Gr ( $PRVA ) to Market Outperform with a price target of 29.

0 · Reply

JarvisFlow Feb. 28 at 3:58 PM

Canaccord Genuity has updated their rating for Privia Health Gr ( $PRVA ) to Buy with a price target of 30.

0 · Reply

Market Cap	2.65B
Revenue (ttm)	1.74B
Net Income (ttm)	14.39M
EPS (ttm)	N/A
PE Ratio	183.42
Forward PE	105.65
Profit Margin	0.83%
Debt to Equity Ratio	0.00

Volume	865,900
Avg Vol	768,436
Day's Range	N/A - N/A
Shares Out	121.92M
Stochastic %K	30%
Beta	0.83
Analysts	Strong Sell
Price Target	$29.20